Status:
UNKNOWN
MAC-cbt Group Therapy for Adults With ADHD
Lead Sponsor:
Peter Tonn
Collaborating Sponsors:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Psychotherapy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study is developed to validate a new short psychotherapeutic group treatment for adults with ADHD diagnosis. The participants will be treated in a monocentric, parallel group randomized superiorit...
Detailed Description
Background: Attention deficit hyperactivity disorder (AD(H)D) symptoms are often assumed to decease in adolescence, however in up to 60% of children, AD(H)D persists into adulthood. Currently, pharmac...
Eligibility Criteria
Inclusion
- adult ADHD
- written informed consent
- stable medication for at least two weeks
- sufficient knowledge of the German language
Exclusion
- personality disorder
- schizophrenia / psychotic disorders
- bipolar disorder
- acute suicidality
- disease of the central nervous system
- no other psychotherapeutic treatment at the time of the study
- pregnancy
- IQ below 70 Points
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03806569
Start Date
March 1 2019
End Date
December 1 2022
Last Update
August 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuropsychiatric Center of Hamburg
Hamburg, Germany, 22769